C20orf166-AS1
c20orf166-as1: An Intriguing Non-Coding RNA Associated with a Spectrum of Diseases
Description
c20orf166-as1 (also known as FENDRR or FIT1) is a long non-coding RNA (lncRNA) located on chromosome 20. LncRNAs are RNA molecules that do not code for proteins but play important roles in gene regulation. c20orf166-as1 has been found to be involved in various cellular processes, including cell cycle regulation, apoptosis, and immune responses.
Associated Diseases
Research has linked c20orf166-as1 to a range of diseases, including:
- Cancer: Overexpression of c20orf166-as1 has been linked to the development and progression of several types of cancer, including breast, lung, colon, and liver cancer.
- Cardiovascular diseases: c20orf166-as1 has been implicated in the development of atherosclerosis, hypertension, and heart failure.
- Neurological disorders: Alterations in c20orf166-as1 expression have been observed in Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
- Immune disorders: c20orf166-as1 has been linked to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
- Other diseases: c20orf166-as1 has also been associated with diabetes, obesity, and infertility.
Did you Know ?
A study published in the journal "Molecular Cancer" found that overexpression of c20orf166-as1 is associated with a 2.3-fold increased risk of developing breast cancer.
Latest Research
Ongoing research is delving into the complex mechanisms by which c20orf166-as1 contributes to different diseases:
- Cancer: Studies suggest that c20orf166-as1 may promote cancer cell growth, migration, and invasion by regulating the expression of genes involved in these processes.
- Cardiovascular diseases: Research indicates that c20orf166-as1 may contribute to atherosclerosis by promoting the formation of plaques in blood vessels.
- Neurological disorders: Animal studies have shown that alterations in c20orf166-as1 expression may disrupt neuronal function and contribute to neurodegenerative diseases.
